[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Connective Tissue Disorders |
Connective Tissue Disease; Dupuytren's Contracture; Mixed Connective Tissue Disease; PXE |
Clinical Trial: Pharmacotherapy and Intensive Treatment - 2
This study is no longer recruiting patients.
Purpose
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Carbamazepine | Phase IV |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Pharmacotherapy and Intensive Treatment
Eligibility
Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Female
Criteria
Location Information
Missouri
University of Kansas, Kansas City, Missouri, 64128, United States
William Haning, M.D., Principal Investigator, University of Kansas
More Information
Record last reviewed: December 2002
Last Updated: December 3, 2004
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000218
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Arthritis Foundation
- ClinicalTrials.gov: Connective Tissue Diseases (National Institutes of Health)

Not Signed In -


